Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-16

Clinical Trial Update: Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission [Phase 4]

View source ↗

Summary

Phase 4 trial update on using Tenofovir to prevent mother-to-child transmission of Hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenofovir (Tenofovir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Hepatitis B Chronic Infection, Pregnancy | Phase 4 | Status: UNKNOWN